Search by Drug Name or NDC

    NDC 68210-1160-03 MUCUS RELIEF 400 mg/1 Details

    MUCUS RELIEF 400 mg/1

    MUCUS RELIEF is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by SPIRIT PHARMACEUTICALS LLC. The primary component is GUAIFENESIN.

    Product Information

    NDC 68210-1160
    Product ID 68210-1160_ee122adf-2860-aab8-e053-2995a90aeb95
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name MUCUS RELIEF
    Proprietary Name Suffix n/a
    Non-Proprietary Name GUAIFENESIN
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 400
    Active Ingredient Units mg/1
    Substance Name GUAIFENESIN
    Labeler Name SPIRIT PHARMACEUTICALS LLC
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 68210-1160-03 (68210116003)

    NDC Package Code 68210-1160-3
    Billing NDC 68210116003
    Package 1 BOTTLE in 1 CARTON (68210-1160-3) / 30 TABLET in 1 BOTTLE
    Marketing Start Date 2018-12-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 3fc2f580-0004-4718-95ce-f329266fe0f1 Details

    Revised: 11/2022